3Kolovou GD, Anagnostopoulou KK. Apolipoprotein E polymorphism, age and coronary heart disease [J]. Ageing Res Rev, 2007, 6(2): 94-108.
4Von Bergmann K, Lutjohann D, Lindenthal B, et al. Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype [J]. J Lipid Res, 2003, 44(1): 193-197.
5von Ballmoos MW, Dubler D, Mirlaeher M, et al. Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients [J]. Arterioscler Thromb Vase Biol, 2006, 26(2) : 359-364.
6Graner M, Kahri J, Varpula M. Apolipoprotein E polymorphism is associated with both carotid and coronary atheroselerosis in patients with coronary artery disease [J]. Nutr Metab Cardiovasc Dis, 2008, 18(4): 271-277.
7Schmitz F, Mevissen V, Krantz C, et al. Robust association of the APOE epsilon4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: the Aachen study [J]. Eur J Clin Invest, 2007, 37(2): 106-108.
8Anuurad E, Rubin J, Lu G, et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is media ted through lipoprotein cholesterol [J]. J Lipid Res, 2006, 47 (11) : 2475-2481.
9Pitsavos C, Choumerianou DM, Skoumas J, et al. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypcrcholesterolaemia [J]. Clin Exp Med, 2005, 5(4): 196-201.
10Kuhlencordt PJ, Hotten S, Schodel J, et al. Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (7) : 1539-1544.
